questionText: To ask the Secretary of State for Health and Social Care, what recent discussions she has had with people with (a) cystic fibrosis and (b) representative organisations on the draft guidance on the future availability of (i) Orkambi, (ii) Symkevi and (iii)
answerText: The National Institute for Health and Care Excellence (NICE) is an independent body and is responsible for leading engagement with interested parties in the development of its recommendations on medicines. NICE has recently consulted on its draft guidance...
heading: Cystic Fibrosis: Drugs